Trial
NCT04186988
[18F]-AraG for the Detection of T-Cell Activation in Advanced Non-small Cell Lung Cancer Patients Undergoing PD-1/PD-L1-Directed Therapy
Early Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of California, Davis
Collaborators
National Cancer Institute (NCI); CellSight Technologies, Inc.
Condition
Advanced Lung Non-Small Cell Carcinoma
Intervention
Fluorine F 18 Ara-G
Why stopped
Unable to recruit to study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-02-01